Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mixed tocotrienols are vitamin E compounds with delta- and gamma-tocotrienol as primary bioactive forms that regulate HMG-CoA reductase enzyme activity. These annatto-derived compounds provide superior cardiovascular protection and antioxidant activity compared to traditional vitamin E supplements.
Reported Benefits (Provisional)
Origin & History
Mixed Tocotrienols are derived from the annatto plant, which is native to South America. They are a form of vitamin E with unique health benefits.
Research Narrative (Provisional)
Research includes studies showing tocotrienols may help lower cholesterol and support heart health. Some studies suggest potential benefits in cancer prevention.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"fat": "1000 mg per serving", "saturated_fat": "0 mg per serving", "trans_fat": "0 mg per serving"}, "micronutrients": {"vitamin_e": {"tocotrienols": "150 mg per serving", "tocopherols": "10 mg per serving"}}, "bioactive_compounds": {"delta-tocotrienol": "90 mg per serving", "gamma-tocotrienol": "50 mg per serving", "alpha-tocotrienol": "10 mg per serving"}, "bioavailability_notes": "Tocotrienols are fat-soluble and best absorbed when taken with dietary fats. They are less prevalent in the diet compared to tocopherols, making supplementation beneficial for achieving optimal levels."}
Reported Mechanism (Provisional)
Mixed tocotrienols inhibit HMG-CoA reductase enzyme through post-transcriptional regulation, reducing cholesterol synthesis more effectively than statins. Delta-tocotrienol activates PPAR-alpha pathways and suppresses inflammatory NF-kB signaling. These compounds also protect cell membranes through superior lipid peroxidation prevention compared to alpha-tocopherol.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 50-200 participants show mixed tocotrienols (100-300mg daily) reduce total cholesterol by 15-30% and LDL cholesterol by 20-25% within 8-12 weeks. Meta-analyses of cardiovascular studies demonstrate significant improvements in arterial stiffness and endothelial function. Antioxidant studies consistently show 40-60% reduction in lipid peroxidation markers, though long-term cardiovascular outcome data remains limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.